Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risk estimation in Barrett's esophagus: biomolecular marker and histopathologic classification].

A Walch1, A Schmitt-Gräff, H Stein

  • 1Universitätsklinikum Freiburg, Pathologisches Institut. walch@ukl.uni-freiburg.de

Zentralblatt Fur Chirurgie
|January 17, 2003
PubMed
Summary

Diagnosing Barrett's esophagus and its neoplasia grades is challenging. While new biomarkers show promise, identifying those predicting cancer progression remains crucial for patient risk assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative motor deficits following elbow flexion reanimation by nerve transfer.

Hand surgery & rehabilitation·2018
Same author

Correlative mass spectrometry imaging, applying time-of-flight secondary ion mass spectrometry and atmospheric pressure matrix-assisted laser desorption/ionization to a single tissue section.

Rapid communications in mass spectrometry : RCM·2017
Same author

In Situ Metabolomics in Cancer by Mass Spectrometry Imaging.

Advances in cancer research·2017
Same author

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.

Leukemia·2015
Same author

High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice.

Molecular metabolism·2015
Same author

CLIP2 as radiation biomarker in papillary thyroid carcinoma.

Oncogene·2014

Area of Science:

  • Gastroenterology and oncology
  • Molecular pathology
  • Cancer biomarker research

Context:

  • Barrett's esophagus (BE) diagnosis and neoplasia grading present significant challenges.
  • Understanding the genetic landscape of BE carcinogenesis is critical for improving patient outcomes.
  • Current diagnostic methods rely heavily on histopathological assessment of intraepithelial neoplasia (IN).

Purpose:

  • To review current knowledge on genetic alterations in Barrett's esophagus carcinogenesis.
  • To discuss emerging biomarkers for cancer risk stratification in BE.
  • To evaluate the utility of immunohistochemical markers in differentiating neoplasia grades and predicting progression.

Summary:

  • Genetic alterations in Barrett's esophagus carcinogenesis are complex and under investigation.

Related Experiment Videos

  • Several novel biomarkers are under evaluation for their potential in assessing cancer risk.
  • Limited immunohistochemical markers aid in distinguishing low- and high-grade intraepithelial neoplasia, but predictors of malignant progression are still needed.
  • The degree of intraepithelial neoplasia remains the current gold standard for evaluating malignant potential in BE.

    • Impact:

    • Improved diagnostic accuracy for Barrett's esophagus and its neoplastic progression.
    • Potential for earlier detection and intervention in high-risk patients.
    • Advancement of personalized medicine approaches in gastrointestinal oncology.